New Treatment For Renal Disease – Part 1 of 3
New Treatment For Renal Disease. Drugs that better lower blood pressure may reduce the risk of early death for people with advanced kidney disease, a renewed study finds. The drugs could also lower patients’ odds of requiring dialysis, the researchers said. The new study out of Taiwan focused on two types of high blood on drugs, angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blockers (ARBs). ACE inhibitors have long been a standby of blood pressure care, and take in drugs such as Altace (ramipril), Vasotec (enalapril) and Lotensin (benazepril, among others).
ARB medications are also used to lower blood pressure, and include medications such as Atacand (candesartan), Cozaar (losartan), and valsartan (Diovan, surrounded by others). Both classes of drugs have been known to delay the progression of chronic kidney disease in patients with and without diabetes, the Taiwanese authors noted. However, most gargantuan studies of ACE inhibitors or ARBs have excluded patients with advanced chronic kidney disease, so it hasn’t been known how these drugs affect this group of patients.